In-depth analysis of data from the RAS-ALS study reveals new insights in rasagiline treatment for amyotrophic lateral sclerosis.
Daniel Zeller, Alexander Emmer, Matthias Boentert, Johannes Prudlo, Simon Witzel, Joachim Schuster, Andrea S Winkler, Johannes Dorst, Susanne Petri, Torsten Grehl, Julian Grosskreutz, Jens Dreyhaupt, Jochen H Weishaupt, Andreas Hermann, Luc Dupuis, Jan Kassubek, Michael T Heneka, Thomas Meyer, Albert C Ludolph, Karla Mönkemöller, Stéphane Dieterlé, Berthold Schrank, Siw Johannesen, Bettina Göricke
European journal of neurology 2024;31(4):e16204